Forgot Password?
Return to Course Listing

CME: Alcohol Use Disorder (AUD): Therapeutic Updates and Best Practices


Activity Description / Statement of Need:


In this online CME self-learning program:

Alcohol use disorder (AUD), referred to colloquially as alcoholism, is an integration of past terms that have include in past as alcohol dependence or abuse, and may be marked by any one of a number of different symptoms or behaviors that include physical cravings, compulsion, guilt, and frequent consumption over an extended period of time. There are about 7.9 million people in the United States who suffer from the disease, but a fraction – 2.2 million people – seek treatment for it. The number of people who are considered heavy drinkers is about double at somewhere between 15.9 and 17.6 million, and just under a quarter of Americans over age 12 reports having engaged in binge drinking at least once in the last month. Alcohol accounts for over 687,000 emergency department visits by people under age 20 per year, and AUD is estimated to cost $223.5 billion per year. Worldwide, 76.3 million people are estimated to have AUDs, and they account for an annual mortality rate of 1.8 million. AUD is largely undertreated, constituting one gap in care and justifying CME.





Introduction, Disclosures

Primer on AUD’s epidemiology, what is known in the neuropathophysiology, screening strategies, and psychosocial impact [Learning Objective #1]

  • Statistics
  • Nature vs. nurture in addictive disease
  • Psychosocial and socioeconomic factors
  • DSM-5 integration of DSM-IV criteria
  • The first step in treatment: prevention – identifying the ‘issue’ before it becomes an issue – the value of the validated screening tools at our disposal
  • Patient case(s)

Treatment of AUD [Learning Objective #3 & 4]

  • Goals of therapy
  • Drugs use in managing patients with AUD
  • Non-adherence to therapy and strategies to overcome
  • Patient case(s)

Summary, conclusions, and best practice recap




Target Audience:

Healthcare professionals who are: psychiatrists, primary care physicians, emergency medicine physicians, physician assistants, nurse practitioners, pharmacists, and those who otherwise commonly treat patients suffering from or have a clinical interest in AUD.

This program is supported by an educational grant from Alkermes.

Release Date: October 13, 2017 -- Expiration Date: October 13, 2019

Faculty: Timothy Fong, MD


Learning Objectives

By the end of the session the participant will be able to:

  • Describe the epidemiology of AUD and outline current and evolving diagnostic criteria
  • Describe challenges to the successful identification of patients with AUD
  • Identify the treatment modalities currently available for management of AUD and apply them to patient cases using evidence-based medicine
  • Develop strategies for recognizing and improving therapeutic adherence in patients treated for AUD



Faculty Disclosure and Resolution of COI

 As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.


Faculty Disclosure:  Timothy Fong, M.D., Professor of Psychiatry Director, UCLA Addiction Psychiatry Fellowship UCLA School of Medicine, Los Angeles, CA is on the Speaker’s Bureau of Indivior, has received Research Support from Connections in Recovery and Constellation Health and is a consultant for Onward, Inc. and Alkermes


Disclosures of Educational Planners: Charles Turck, PharmD has no relevant conflicts of interest to disclose.


Commercial Support Disclosure: This program is supported by an educational grant from Alkermes


  • Read the learning objectives above
  • Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
  • View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
  • Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
  • Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.

Cultural/Linguistic Competence & Health Disparities

System Requirements

Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh

*Required to view Printable PDF Version

Perform Pre-Test (optional)

Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.

Additional Courses That Are Related To This Activity

Best Practices and Advances in Treatment Strategies in Bipolar Disorder Pharmacotherapy

Schizophrenia: Updates from the American Psychiatric Association Annual Meeting (APA) 2017

Alcohol Use Disorder (AUD): Therapeutic Updates and Best Practices

Major Depressive Disorder (MDD): Updates from the American Psychiatric Association Annual Meeting (APA) 2017